Skip to content
Member Newsletters · · 4 min read

Causeartist Weekly #311: Ethical Chocolate, Clean Energy AI, and Sustainable Farm Grants

Causeartist Weekly #311: Ethical Chocolate, Clean Energy AI, and Sustainable Farm Grants

Hey friends,

Welcome to this week's edition. We’re exploring how "old-school" industries—from chocolate to aid distribution—are being radically modernized.

This week, we dive into Tony’s Chocolonely, a brand that turned a supply chain nightmare into a global movement. We also look at AidKit, which is using human-centered AI to ensure emergency cash reaches those in need with dignity, and we spotlight Lupus Ventures, a first-of-its-kind philanthropic fund bridging the "valley of death" for autoimmune research.

From $115M geothermal raises to $10M grants for Pennsylvania farmers, the scale of impact capital this week is truly staggering.

Let's get to it.

— Grant


How AidKit Is Modernizing Aid Distribution With Technical Infrastructure

In this episode, we speak with Brittany Christenson, CEO of AidKit. Originally a rapid-response solution during the pandemic, AidKit has evolved into permanent infrastructure for fair and scalable aid.

We discuss how they use "human-in-the-loop" AI to verify identities and deliver $385 million in assistance across 110,000+ recipients, ensuring that efficiency never comes at the cost of human dignity.

Listen to the full episode


Impact Business Case Study: Tony’s Chocolonely

Tony's Chocolonely transformed from a Dutch journalist's investigative project into a $200+ million chocolate company by making supply chain transparency its core competitive advantage.

The business operates on three strategic pillars:

Tony's reached profitability in 2013 and has grown revenue at approximately 25-30% annually since 2016. The company holds 18% market share in Netherlands chocolate and expanded to the United States in 2015, where it now generates roughly 20% of total revenue.

Unlike most mission-driven food brands that exit to CPG conglomerates, Tony's remains independent with a governance structure designed to prevent acquisition by companies that do not meet their sourcing standards.

Read the full case study


Inside Lupus Ventures: Catalyzing Autoimmune Breakthroughs

We sit down with the team behind Lupus Ventures, the newly launched philanthropic venture fund of the Lupus Research Alliance.

With over 140 therapies currently in clinical trials, the fund is stepping in to provide the high-risk, early-stage capital that traditional VCs often avoid.

This interview explores their "bench-to-bedside" strategy and how they are leveraging deep scientific expertise to accelerate life-changing treatments for millions.

Read full interview


🗞️ News and Headlines


🌎 Events and Opportunities


💰 Funding and Capital Watch

Grant Trahant
Founder | Causeartist | Causeartist Studio
Host | Disruptors for Good + Investing in Impact 
Venture Partner | Pay it Forward Ventures
Connect: LinkedIn | X

Ask AI about Causeartist
Grant Trahant

Grant Trahant

Founder of Causeartist and Partner at Pay it Forward Ventures

View all posts

Read next

Ask AI about Causeartist
ChatGPT Perplexity Gemini Grok Claude